Ultrafiltration for acute decompensated heart failure

References

• Stevenson LW. Tailored therapy to hemodynamic goals for advanced heart failure. Eur. J. Heart Fail. 1(3), 251–257 (1999).
   Google Scholar
• Nohria A, Sui WT, Fang JC et al. Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure. J. Am. Coll. Cardiol. 41(10), 1797–1804 (2003).
   PubMed Web of Science ®Google Scholar
• Brater DC. Diuretic therapy. N. Engl. J. Med. 339(6), 387–339 (1998).
   PubMed Web of Science ®Google Scholar
• Sica DA, Gehr TW. Diuretic combinations in refractory oedema states: pharmacokinetic–pharmacodynamic relationships. Clin. Pharmacokinet. 30(3), 229–249 (1996).
   PubMed Web of Science ®Google Scholar
• Stanton BA. Adaptation of distal tubule and collecting duct to increased Na delivery. Am. J. Physiol. 255, F1269–F1275 (1988).
   Google Scholar
• Neuberg GW, Miller AB, O’Connor CM et al. Diuretic resistance predicts mortality in patients with advanced heart failure. Am. Heart J. 144(1), 31–38 (2002).
   PubMed Web of Science ®Google Scholar
• Bayliss J, Norell M, Canepa-Anson R, Sutton G, Poole-Wilson P. Untreated heart failure: clinical and neuroendocrine effects of introducing diuretics. Br. Heart J. 57(1), 17–22 (1987).
   PubMedGoogle Scholar
• Francis GS, Siegel RM, Goldsmith SR et al. Acute vasoconstrictor response to intravenous furosemide in patients with chronic congestive heart failure: activation of the neurohumoral axis. Ann. Int. Med. 103(1), 1–6 (1985).
   PubMed Web of Science ®Google Scholar
• Agostini PG, Marenzi GC, Lauri GF et al. Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. Am. J. Med. 96, 191–199 (1994).
   PubMedGoogle Scholar
• Firth JD, Raine AE, Ledingham JG. Raised venous pressure: a direct cause of renal sodium retention in oedema? Lancet 1(8593), 1033–1035 (1988).
   PubMed Web of Science ®Google Scholar
• Marenzi GC, Lauri G, Grazi M et al. Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. J. Am. Coll. Cardiol. 38(4), 963–968 (2001).
   PubMed Web of Science ®Google Scholar
• Cuffe MS, Califf RM, Adams KF et al. Short-term intravenous milrinone for acute exacerbation of chronic heart failure. J. Am. Med. Assoc. 287(12), 1541–1547 (2002).
   PubMed Web of Science ®Google Scholar
• McCurley JM, Hanlon SU, Wei SK, Wedam AF, Michalski M, Haigney MC. Furosemide and the progression of left ventricular dysfunction in experimental heart failure. J. Am. Coll. Cardiol. 44(6), 1301–1307 (2004).
   PubMed Web of Science ®Google Scholar
• Butler J, Forman DE, Abraham WT et al. Relationship between heart failure treatment and development of worsening renal function among hospitalized patients. Am. Heart J. 147(2), 331–338 (2004).
   PubMed Web of Science ®Google Scholar
• Hillege HL, Girbes ARJ, De Kam PJ et al. Renal function, neurohormonal activation, and survival in patients with chronic heart failure. Circulation 102(2), 203–210 (2000).
   PubMed Web of Science ®Google Scholar
• Elkayam U, Akhter MW, Singh H, Khan S, Usman A. Comparison of effects on left ventricular filling pressure of intravenous nesiritide and high-dose nitroglycerine in patients with decompensated heart failure. Am. J. Cardiol. 93, 237–240 (2004).
   PubMed Web of Science ®Google Scholar
• Publication Committee for the VMAC Investigators. J. Am. Med. Assoc. 287(12), 1531–1540 (2002).
   PubMed Web of Science ®Google Scholar
• Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation 111, 1487–1491 (2005).
   PubMed Web of Science ®Google Scholar
• Sackner-Bernstein JD, Kowalski M, Fox M, Aaronson KD. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. J. Am. Med. Assoc. 293(15), 1900–1905 (2005).
   PubMed Web of Science ®Google Scholar
• Wang DJ, Dowling TC, Meadows D et al. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Circulation 110, 1620–1625 (2004).
   PubMed Web of Science ®Google Scholar
• Peacock WF, Emerman CL. Safety and efficacy of nesiritide in the treatment of decompensated heart failure in observation patients – the PROACTION trial. J. Am. Coll. Cardiol. 41(Suppl. 6A), 336A (2003).
   Google Scholar
• Agostoni PG, Marenzi GC, Pepi M et al. Isolated ultrafiltration in moderate congestive heart failure. J. Am. Coll. Cardiol. 21(2), 424–431 (1993).
   PubMed Web of Science ®Google Scholar
• Fonarow GC, Stevenson LW, Steimle AE et al. Persistently high left ventricular filling pressures predict mortality despite angiotensin converting enzyme inhibition in advanced heart failure. Circulation 90(2), I488 (1994).
   Google Scholar
• Lucas C, Johnson W, Hamilton MA et al. Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. Am. Heart J. 140(6), 840–847 (2000).
   PubMed Web of Science ®Google Scholar
• Jaski BE, Ha J, Denys BG et al. Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. J. Card. Fail. 9(3), 227–231 (2003).
   PubMed Web of Science ®Google Scholar
• Bart BA, Boyle AJ, Bank AJ et al. Ultrafiltration versus usual care for hospitalized patients with heart failure: relief for acutely fluid overloaded patients with decompensated congestive heart failure – the RAPID – heart failure Trial. J. Card. Fail. 10(4 Suppl.), S23 (2004).
   Google Scholar
• Costanzo MR, Saltzberg M, O’Sullivan J et al. EUPHORIA: early ultrafiltration in patients with decompensated heart failure and observed resistance to intervention with diuretic agents. J. Card. Fail. 10(4 Suppl.), S78 (2004).
   Google Scholar
• Marenzi G, Grazi S, Giraldi F et al. Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. Am. J. Med. 94(1), 49–56 (1993).
   PubMed Web of Science ®Google Scholar
• Canaud B, Leblanc M, Leray-Moragueus H et al. Slow continuous and daily ultrafiltration for refractory congestive heart failure. Nephrol. Dial. Transpl. 13(Suppl. 4), 51–55 (1998).
   PubMedGoogle Scholar
• Asaba H, Bergstrom J, Furst P, Shaldon S, Wiklund S. Treatment of diuretic resistant fluid retention with ultrafiltration. Acta Med. Scand. 204(3), 145–148 (1978).
   PubMedGoogle Scholar
• Rimondini A, Cipolla CM, Della Bella P et al. Hemofiltration as short-term treatment for refractory congestive heart failure. Am. J. Med. 83, 43–47 (1987).
   PubMed Web of Science ®Google Scholar
• Sheppard R, Panyon J, Pohwani AL et al. Intermittent out-patient ultrafiltration for the treatment of severe refractory congestive heart failure. J. Card. Fail. 10(5), 380–3383 (2004).
   PubMedGoogle Scholar